1. Home
  2. ETNB vs UNFI Comparison

ETNB vs UNFI Comparison

Compare ETNB & UNFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • UNFI
  • Stock Information
  • Founded
  • ETNB 2018
  • UNFI 1976
  • Country
  • ETNB United States
  • UNFI United States
  • Employees
  • ETNB N/A
  • UNFI N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • UNFI Food Distributors
  • Sector
  • ETNB Health Care
  • UNFI Consumer Discretionary
  • Exchange
  • ETNB Nasdaq
  • UNFI Nasdaq
  • Market Cap
  • ETNB 1.5B
  • UNFI 1.4B
  • IPO Year
  • ETNB 2019
  • UNFI 1996
  • Fundamental
  • Price
  • ETNB $9.59
  • UNFI $28.21
  • Analyst Decision
  • ETNB Strong Buy
  • UNFI Hold
  • Analyst Count
  • ETNB 8
  • UNFI 8
  • Target Price
  • ETNB $26.43
  • UNFI $27.00
  • AVG Volume (30 Days)
  • ETNB 1.5M
  • UNFI 1.3M
  • Earning Date
  • ETNB 08-08-2025
  • UNFI 06-10-2025
  • Dividend Yield
  • ETNB N/A
  • UNFI N/A
  • EPS Growth
  • ETNB N/A
  • UNFI N/A
  • EPS
  • ETNB N/A
  • UNFI N/A
  • Revenue
  • ETNB N/A
  • UNFI $32,243,000,000.00
  • Revenue This Year
  • ETNB N/A
  • UNFI $4.51
  • Revenue Next Year
  • ETNB N/A
  • UNFI $0.06
  • P/E Ratio
  • ETNB N/A
  • UNFI N/A
  • Revenue Growth
  • ETNB N/A
  • UNFI 6.62
  • 52 Week Low
  • ETNB $4.16
  • UNFI $12.00
  • 52 Week High
  • ETNB $11.84
  • UNFI $34.76
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 41.01
  • UNFI 66.33
  • Support Level
  • ETNB $9.82
  • UNFI $27.22
  • Resistance Level
  • ETNB $10.48
  • UNFI $28.39
  • Average True Range (ATR)
  • ETNB 0.49
  • UNFI 1.03
  • MACD
  • ETNB -0.14
  • UNFI 0.55
  • Stochastic Oscillator
  • ETNB 3.70
  • UNFI 97.13

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About UNFI United Natural Foods Inc.

United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.

Share on Social Networks: